News

In 2023, an emergency colonoscopy led to Michael's diagnosis of stage 3 cancer. Because of his experience, Michael Kathrens, 70, advocates for proactive health screenings and being an advocate for your own health.

This week, Marc Roth, MD, medical director of gastrointestinal oncology at Saint Luke’s Cancer Institute and interim chief of medical oncology, is breaking down these latest advancements and what they mean for patients.

Weeks shy of the bar exam, the trajectory of Jackson’s life was rocked off course when he was diagnosed with stage 3 colon cancer. The 26-year-old’s diagnosis was an obstacle that he refused to let topple him.

While chemotherapy, radiation, and surgeries are common for most cancer treatments, immunotherapy is continuing to allow some patients to forgo these often harsh and invasive methods altogether.

This MS awareness month, Dr. Carolina Garcia, a neurologist at Saint Luke's Comprehensive Multiple Sclerosis Center, discusses diagnosing and treating this inflammatory and presumed autoimmune condition.

Alexis Ellington has a renewed outlook on life after being the first Saint Luke's patient to receive a new cancer treatment called Bispecific T-cell Engagers therapy, or BiTE.

Growing research shows why popular GLP-1 weight loss medications might be beneficial for people with multiple sclerosis, but the jury’s still out.

Empower yourself by learning all you can about therapies for multiple sclerosis.

Dr. Dawn Jones joins Health News You Can Use to talk about recent advances in breast surgery for patients with cancer.

After discovering she had an uncommon somatic gene mutation, Laurie Hamilton became determined to help those after her by participating in clinical trials and investing in scientific research for advanced breast cancer.